Gout
Showing 26 - 50 of 197
NLRP3 Inflammasome in Intercritical Gout
Active, not recruiting
- Gout
- Joint Biopsy
-
Beverly Hills, CaliforniaAttune Health Research Inc.
Jul 18, 2022
Gout, Arthritis, Gouty, Hyperuricemia Trial in Phoenix, Tucson, Myrtle Beach (AR882 Dose 1, AR882 Dose 2, Allopurinol Tablet)
Not yet recruiting
- Gout
- +3 more
- AR882 Dose 1
- +2 more
-
Phoenix, Arizona
- +2 more
Jul 13, 2022
Gout Trial (the Aquatic exercises +Traditional physical therapy programs +anti-hyperuricemia medication, traditional physical
Not yet recruiting
- Gout
- the Aquatic exercises +Traditional physical therapy programs +anti-hyperuricemia medication
- traditional physical therapy + anti-hyperuricemia medication
- (no location specified)
Jul 7, 2022
Gout Trial in Taipei (Placebo, AC-201, Febuxostat)
Completed
- Gout
- Placebo
- +2 more
-
Taipei, TaiwanTaipei Veteran General Hospital (TVGH)
Jun 2, 2022
Gout Trial in Shanghai (SHR4640 dose1, SHR4640 dose2, Placebo oral tablet)
Completed
- Gout
- SHR4640 dose1
- +3 more
-
Shanghai, Shanghai, ChinaRenJi Hospital Shanghai Jiaotong University School of Medicine
Jun 9, 2022
Systemic Lupus Erythematosus, Sjogren's Syndrome, Inflammatory Myositis Trial in Rochester (mRNA COVD19 vaccine)
Terminated
- Systemic Lupus Erythematosus
- +7 more
- mRNA COVD19 vaccine
-
Rochester, MinnesotaMayo Clinic in Rochester
May 31, 2022
Gout Trial in Qingdao (Colchicine)
Recruiting
- Gout
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
May 6, 2022
Arthritis, Gout, Fibromyalgia Trial in Columbia (Phone-Based Walk With Ease)
Recruiting
- Arthritis
- +5 more
- Phone-Based Walk With Ease
-
Columbia, South CarolinaUniversity of South Carolina
Apr 7, 2022
Gout Trial in Zibo (HEC93077, Placebo)
Recruiting
- Gout
- HEC93077
- Placebo
-
Zibo, Shandong, ChinaPeking Universicity Care of Luzhong Hospital
Apr 8, 2022
Gout Trial in Lomme, Paris (ultrasonography, DECT)
Completed
- Gout
- ultrasonography
- DECT
-
Lomme, France
- +2 more
Apr 6, 2022
Gout, Chronic Kidney Diseases Trial in Southend on Sea (Anakinra 100mg and Placebo Depo-Medrone, Depo-Medrone 120mg and Placebo
Completed
- Gout
- Chronic Kidney Diseases
- Anakinra 100mg and Placebo Depo-Medrone
- Depo-Medrone 120mg and Placebo (Anakinra)
-
Southend on Sea, Essex, United KingdomSouthend Hospital
Apr 5, 2022
Chronic Uncontrolled Gout, Gout, Uncontrolled Gout Trial in United States (Pegloticase with MTX)
Recruiting
- Chronic Uncontrolled Gout
- +2 more
- Pegloticase with MTX
-
Anchorage, Alaska
- +12 more
Mar 23, 2022
Network Meta-analysis of Intermittent Fasting and
Active, not recruiting
- Obesity
- +10 more
- Intermittent Fasting
-
Toronto, Ontario, Canada
- +1 more
Mar 24, 2022
Rheumatic Diseases, Gout, Adherence, Medication Trial in Boston (Cue-Reward Intervention, Cue-Reward Intervention with possible
Recruiting
- Rheumatic Diseases
- +3 more
- Cue-Reward Intervention
- Cue-Reward Intervention with possible intensification
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 17, 2022
Gout, Low Medication Adherence, Health Related Quality of Life Trial in Birmingham, Saint Louis, Philadelphia (Gout Storytelling
Completed
- Gout
- +2 more
- Gout Storytelling Video Intervention
-
Birmingham, Alabama
- +2 more
Mar 8, 2022
Arthritis, Rheumatoid Arthritis, Fibromyalgia Trial in Seattle (Tele-Enhance Fitness, In-person Enhance Fitness)
Recruiting
- Arthritis
- +5 more
- Tele-Enhance Fitness
- In-person Enhance Fitness
-
Seattle, WashingtonUniversity of Washington
Mar 1, 2022
Gout, Hyperuricemia Trial in United States (LC350189 formulated capsule, Placebo)
Completed
- Gout
- Hyperuricemia
- LC350189 formulated capsule
- Placebo
-
Birmingham, Alabama
- +33 more
Jan 11, 2022
Gout, Hyperuricemia Trial in Las Vegas (LC350189 Tablet, LC350189 Capsule)
Completed
- Gout
- Hyperuricemia
- LC350189 Tablet
- LC350189 Capsule
-
Las Vegas, NevadaPPD
Dec 15, 2021
Hyperuricemia, Gout, Qt Interval, Variation in Trial in Austin (LC350189 200mg, Placebo, Moxifloxacin 400mg)
Completed
- Hyperuricemia
- +2 more
- LC350189 200mg
- +3 more
-
Austin, TexasPPD
Dec 15, 2021
Gout Trial in Perth (XNW3009, Placebo)
Completed
- Gout
- XNW3009
- Placebo
-
Perth, West Austrialia, AustraliaLinear Clinical Research
Jan 4, 2022
New BI-specifiC Antibody Towards Dendritic Cells on Inflammation
Completed
- Rheumatoid Arthritis
- +2 more
- Puncture
-
Tours, FranceRheumatology Department, University Hospital, Tours
Dec 22, 2021
ive Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol
Completed
- Gout
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 15, 2021